[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@_Biotech_iQ Biotech iQBiotech iQ posts on X about $advm, $lly, $autl, $dawn the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks cryptocurrencies countries
Social topic influence $advm, $lly, $autl, $dawn, $dcth, $edap, $swtx, dawn, $vltlf, exxon mobil
Top accounts mentioned or mentioned by @amaymd @plainyogurt21 @fwcweather @jfais20 @alexpitti @9rbiscuit @jorgemariposas @emcclintock @biotechtradersd @cal9797 @logicalthesis @geneinvesting @kienbock253951 @biotechscanner @pmzw75 @pennycheck @cvlm03 @justiceforbmd @respekchemistry @mathcoredad
Top assets mentioned Adverum Biotechnologies, Inc. Common Stock (ADVM) Eli Lilly and Company (LLY) Dawn Protocol (DAWN) SpringWorks Therapeutics, Inc. Common Stock (SWTX) Exxon Mobil (XOM)
Top posts by engagements in the last XX hours
"$ADVM $LLY Is it just me or does the ADVM deal smell a little like desperation"
X Link 2025-10-24T13:29Z 2441 followers, 2572 engagements
"$AUTL $DAWN $DCTH $EDAP $SWTX"
X Link 2025-01-13T13:32Z 2435 followers, 2117 engagements
"I appreciate all the great insights. I think $VLTLF is very interesting at this valuation. DLE from oilfield operations isn't unique to VLTLF: ExxonMobil and Standard Lithium are two of the other publicly traded companies developing this technology (DLE from oilfield operations) in North America and there are some private and ex-US companies as well. However SLI (still pre-revenue) sits at a $1B+ valuation vs. VLTLF's sub $100M valuation; to be fair however SLI is somewhat better capitalized. I first became interested in VLTLF because of my investment in TTI (BiQ c/b $3.04) which is partnered"
X Link 2025-12-01T17:00Z 2435 followers, XXX engagements
"Per Bloomberg the House passed a Bill to extend the PRV program for rare pediatric diseases. The Bill still needs to be approved by the Senate. I know many people feel the PRV program is a giveaway to pharma but I consider it to be an important part of the ecosystem and I thought it was unfortunate that Congress allowed it to expire. Hopefully the Bill passes in the Senate"
X Link 2025-12-03T04:58Z 2434 followers, 2276 engagements
"$VTYX $ABVX All the attention is on VTYX's NLRP3 pipeline but I still think VTX002 could be an underappreciated sleeper asset. This is a quick-and-dirty comparison so I might have missed something (feedback welcome). Full disclosure: I am long VTYX (Adj c/b $.37 which is inclusive of prior trading profits.)"
X Link 2025-12-06T17:43Z 2441 followers, 11K engagements
"The hypothesis which remains unproven pending further data is that $VTYX's VTX002 is highly selective for S1P1 vs other subtypes thus preserving immune function vs less selective S1P inhibitors"
X Link 2025-12-06T18:54Z 2440 followers, XXX engagements